Out-Of-Pocket Costs Without Insurance Without insurance, GLP-1 drugs such as Wegovy and Zepbound can cost more than $1,000 per month, making them inaccessible for many patients
DOI:10.1093/eurheartjsupp/suae011
All of the above may explain the inconsistency of preclinical and clinical results and is a challenge for both clinicians and fundamental scientists, requiring the development of new perspectives and strategic approaches
For example, a person with obesity who also wants to quit smoking getting GLP-1 may help that person hit two birds (with) one stone simultaneously addressing obesity and also help them quit smoking
Most patients experience significant weight regain after stopping GLP-1 medications, with clinical trials showing regain of substantial weight within the first year
What you cant do with standard medication forms is change the preset dosage